文献速递瓣膜病与结构性心脏病冠心病

主动脉瓣狭窄外科换瓣术后预期寿命与相对生存的决定因素

Life expectancy and determinants of relative survival following surgical aortic valve replacement for aortic stenosis.
PubMed 文献 · Heart · 2026-03-18

该研究基于西澳大利亚心脏瓣膜研究数据库1287例因中度及以上主动脉瓣狭窄行外科主动脉瓣置换术的患者,采用灵活参数模型评估相对生存。中位随访47个月,全因30天、1年、5年和10年相对生存分别为97.3%、97.2%、93.0%和83.3%。左室射血分数受损、显著二尖瓣反流、原住民身份、糖尿病和肾功能不全是长期超额死亡的独立预测因素。

要点

  • SAVR术后10年相对生存降至83.3%,未完全恢复正常预期寿命。
  • LVEF受损、显著二尖瓣反流、肾功能不全和糖尿病预测长期超额死亡。
  • 原住民身份与长期超额死亡独立相关,需关注术后随访公平性。

核心结论

  • 当代人群中,因显著主动脉瓣狭窄行SAVR后相对生存低于年龄、性别和手术年份匹配的一般人群。

研究设计与样本

  • 基于西澳大利亚心脏瓣膜研究数据库,纳入1287例因中度及以上主动脉瓣狭窄行SAVR的患者(中位年龄71岁,32%女性),使用灵活参数模型估计相对生存。

主要发现

  • 中位随访47个月期间247例(19%)死亡,全因30天、1年、5年和10年相对生存分别为97.3%、97.2%、93.0%和83.3%。
  • LVEF 45%-60%超额HR 1.97(95%CI 1.11-3.51,p=0.02),30%-45%超额HR 2.40(95%CI 1.24-4.64,p=0.01),<30%超额HR 2.96(95%CI 1.18-7.39,p=0.02)。
  • 显著二尖瓣反流超额HR 2.28(95%CI 1.29-4.03,p=0.005),原住民身份超额HR 4.53(95%CI 2.03-10.12,p<0.001),糖尿病超额HR 2.30(95%CI 1.44-3.68,p<0.001)。
  • eGFR 30-59 mL/kg/1.73 m2超额HR 2.74(95%CI 1.33-5.65,p=0.006),eGFR 0-29 mL/kg/1.73 m2超额HR 5.75(95%CI 2.36-13.99,p<0.001)。
  • 年龄、性别、手术年份、同期冠状动脉旁路移植术和症状状态与长期超额死亡无关。

临床怎么用

  • 对SAVR术后患者应识别LVEF受损、显著二尖瓣反流、糖尿病和肾功能不全等高危因素并加强术后随访。
  • 原住民患者术后可能需针对性随访策略以改善长期生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: Surgical aortic valve replacement (SAVR) improves survival in severe, symptomatic aortic stenosis (AS), but whether it fully restores life expectancy is uncertain. This study aimed to evaluate long-term relative survival following SAVR compared with the general population and identify predictors of any residual survival discrepancies. METHOD: A total of 1287 patients (median age 71 (63-77) years, 32% female) undergoing SAVR for ≥moderate AS were identified from the Western Australian Heart Valves Study database. Flexible parametric models were used to estimate relative survival. RESULTS: Over a median follow-up of 47 (23-81) months, 247 (19%) patients died. All-cause 30-day, 1-year, 5-year and 10-year relative survivals were 97.3%, 97.2%, 93.0% and 83.3%, respectively, compared with an age-matched, sex-matched and year-matched general population. Flexible multivariable modelling indicated impaired left ventricular ejection fraction (LVEF) (45%-60%, excess HR 1.97, 95% CI 1.11 to 3.51, p=0.02; 30%-45%, excess HR 2.40, 95% CI 1.24 to 4.64, p=0.01; <30%, excess HR 2.96, 95% CI 1.18 to 7.39, p=0.02), significant mitral regurgitation (MR) (excess HR 2.28, 95% CI 1.29 to 4.03, p=0.005), Indigenous status (excess HR 4.53, 95% CI 2.03 to 10.12, p<0.001), diabetes mellitus (excess HR 2.30, 95% CI 1.44 to 3.68, p<0.001), estimated glomerular filtration rate (eGFR) 30-59 mL/kg/1.73 m2 (excess HR 2.74, 95% CI 1.33 to 5.65, p=0.006) and eGFR 0-29 mL/kg/1.73 m2 (excess HR 5.75, 95% CI 2.36 to 13.99, p<0.001) were independently associated with long-term excess mortality relative to that of the national comparator, whereas age, sex, year of surgery, concomitant coronary artery bypass graft surgery and symptom status were not. CONCLUSION: In a contemporary population, relative survival following SAVR for significant AS was reduced compared with an age-matched, sex-matched and year-matched general population. Impaired LVEF, significant MR, Indigenous status, renal impairment and diabetes mellitus were independent predictors of long-term excess mortality. Timely intervention and optimised postoperative follow-up may be crucial for the restoration of normal life expectancy following SAVR.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Butcher SC, Lewin S, Budgeon CA, et al. Life expectancy and determinants of relative survival following surgical aortic valve replacement for aortic stenosis. Heart. 2026. PMID: 41850785. doi:10.1136/heartjnl-2025-327029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。